Chartwell Investment Partners, LLC G1 Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$16.51 - $51.33 $1.35 Million - $4.19 Million	-81,580 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$43.15 - $67.97 $4,875 - $7,680	113 Added 0.14%	81,580 $4.27 Million
Q2 2018 Aug 09, 2018	SELL	$35.06 - $51.17 $173,126 - $252,677	-4,938 Reduced 5.71%	81,467 $3.54 Million
Q1 2018 May 08, 2018	BUY	$19.05 - $41.76 $34,918 - $76,546	1,833 Added 2.17%	86,405 $1.71 Million
Q1 2018 May 08, 2018	SELL	$19.05 - $41.76 $34,918 - $76,546	-1,833 Reduced 2.12%	84,572 $3.13 Million
Q4 2017 Feb 08, 2018	SELL	$19.01 - $26.2 $116,968 - $161,208	-6,153 Reduced 6.65%	86,405 $1.71 Million
Q3 2017 Nov 08, 2017	BUY	$12.53 - $27.12 $1.16 Million - $2.51 Million	92,558	92,558 $2.3 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.